Skip to content
zameds

Aripiprazole (Oriza, Tharipi)

Aripiprazole

Acino Pharma (Pty) Ltd

Every registration of this product has been cancelled.

Registration

Applicant
Acino Pharma (Pty) Ltd
Registrations
8

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Oriza 5

EACH TABLET CONTAINS: ARIPIPRAZOLE 5,0 mg

548028448/2.6.5/0284CancelledNot determinedNone
Oriza 10

EACH TABLET CONTAINS: ARIPIPRAZOLE 10,0 mg

1048028548/2.6.5/0285CancelledNot determinedNone
Oriza 15

EACH TABLET CONTAINS: ARIPIPRAZOLE 15,0 mg

1548028648/2.6.5/0286CancelledNot determinedNone
Oriza 30

EACH TABLET CONTAINS: ARIPIPRAZOLE 30,0 mg

3048028748/2.6.5/0287CancelledNot determinedNone
Tharipi 5

EACH TABLET CONTAINS: ARIPIPRAZOLE 5,0 mg

548105648/2.6.5/1056CancelledNot determinedNone
Tharipi 10

EACH TABLET CONTAINS: ARIPIPRAZOLE 10,0 mg

1048105748/2.6.5/1057CancelledNot determinedNone
Tharipi 15

EACH TABLET CONTAINS: ARIPIPRAZOLE 15,0 mg

1548105848/2.6.5/1058CancelledNot determinedNone
Tharipi 30

EACH TABLET CONTAINS: ARIPIPRAZOLE 30,0 mg

3048105948/2.6.5/1059CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C23H27Cl2N3O2448.40 g/mol

7-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one

Drag to rotate. Structure from PubChem CID 60795.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles